Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Medtronic plc (MDT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
82.66-0.90 (-1.08%)
At close: 04:00PM EDT
82.66 0.00 (0.00%)
After hours: 07:59PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • D
    DennisK
    new 12 month low and now 3%
  • R
    Rex
    Waiting for $72
    Bullish
  • R
    Robert
    Management is important - I think MDT needs a change at the top.
  • B
    Bill mddb
    Disappointing market reaction to results expected. They said supply chains were opening up and expect a good 2H. They did what they said they would do so I expect metrics to improve.
  • L
    LA
    MDT needs new CEO
  • B
    Bill mddb
    I saw a PR from MDT that said production in Puerto Rico was back on line after 3 days. They had minor flooding in a plant. So that should not be the cause of today's weakness. I'm hoping it was.
  • H
    Harmony
    Starting to look good, I'd start buying some at its long term available pe of $67
  • B
    Bill mddb
    Hurricane Fiona cut the power to most of Puerto Rico, just like the big storm 3-4 years ago. I believe that was 2018 and MDT had 5 factories in Puerto Rico. The prior storm messed up a material amount of diabetes device production. It hurt quarterly earnings. I believe the main diabetes manufacturing is now done in Northridge California. Some or all of MDT weakness is probably due to Fiona hitting San Juan and potentially hurting inventories.
  • F
    Frederick B
    Any ideas why MDT is struggling to get supply out? What do employees think about Martha?
  • P
    Paula
    $MDT numbers on pump sales not a good macro for Tandem. It’s going lower.
  • B
    Bill mddb
    The personal monitoring device could become a material service. The initial monitoring could be expanded with devices and implants to monitor just about everything. Medicare approval could give it a long runway. The "BioButton" could replace a lot of what doctors do which is prescribe and review tests.
  • J
    JonK
    MDT has huge backorder issues involving key products. Failure to supply, will cause many contracts currently in place to become null and void. Hospitals are actively seeking new suppliers for these key products (Ligasure for example). How long will this last and even more importantly, how long will it take to regain that lost business? Proceed with caution IMO, this is an open door for competitors to get footholds in places MDT has been dominant.
  • D
    DennisK
    new 12 month low...yikes
  • H
    Huey
    They are making money so the market will react!
    Bullish
  • m
    marek
    90 is the new ceiling for MDT. How far is the floor?
  • A
    Adam
    This is not a comment on the valuation or fundamentals, was just an interesting article concerning Medtronic I read from the latest issue of Harper's magazine: A Hole in the Head by Zachary Siegel -- Can a brain implant treat drug addiction?
  • L
    Life
    buy ENPH
  • L
    La
    $95 in a short horizon.
Advertisement
Advertisement